Search ARM

Other Industry Events

AAT's European Advanced Therapies Investor Day

November 27, 2013

The Alliance for Advanced Therapies presents
First European Advanced Therapies Investor Day

For the first time in Europe, the Advanced Therapies Investor Day will provide a unique platform to inform investors, brokers, analysts, financial journalists and others of the latest developments, trends and potential of advanced therapies in Europe. The programme will secure exclusive access to the sector’s leading European companies and other stakeholders a unique opportunity for face-to-face meetings and press interviews with companies senior executives and major players in this field.

Comprehensive Overview of Strategic and Financial Trends 
The morning session will provide comprehensive overview of strategic and financial trends in European advanced therapies. What does the sector re-present and what are the perspectives? What is the financial performance of the sector? What are the trends in technology and product development? What are the financing opportunities in Europe? 

The morning will start with some key note presentations from experts in the field and will be followed by dynamic discussions with key opinion leaders, top VCs, leading analysts, and company senior executives to give participants: 
Recent financial and strategic developments in advanced therapies 
An overview of the most important advances in the field and future developments
An understanding of the latest investment trends and opportunities in Europe. 

Company Presentations 
In the afternoon, 10 to 12 of the most important advanced therapies developing companies in Europe will give company presentations and will provide exclusive insights on their latest technology and development progress.

Confirmed Speakers 
Mark W. Lowdell, University College London Medical School 
Alain Baetens, NYSE Euronext 
Oscar Izeboud, Kempen & Co Daniel Anizon, Invest Securities 
Alain Parthoens, Vesalius Biocapital 
CEO’s of several companies: Kiadis, Cell2B, Promethera Biosciences, TiGenix, Reneuron, Cardio3 Biosciences, ATMI , etc. 

Who Should Attend 
The First European Advanced Therapies Investor Day is aimed at professionals from: 
Institutional Investors 
Life sciences analysts 
Venture Capital 
Financial and life sciences press 
Executives from advanced therapy companies. 

Wednesday, November 26, 2013
10:00 am – 17:30 pm
Place de la Bourse – Beursplein
1000 Brussels, Belgium

Free for VCs, analysts, brokers, and other representatives of financial institutions as well as journalists. 
A registration fee of € 75,- will be required for industry and other participants.

Join Now 
Register here:
For further information: